Recursion Pharmaceuticals Summit Therapeutics: 2026 Insight
Two biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
Choosing between a Sep Ira and a Simple Ira can be challenging. Discover the key factors to consider for your retirement savings strategy.
15,615 articlesTwo biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
A prominent oil strategist argues the Iran war premium is inflating prices, suggesting oil could trade in the $40s if...
A growing number of U.S. cities are linking density design to how banks underwrite loans, aiming to stretch affordabi...
USA Rare Earth's stock dropped 15.7% in February as broad markets wobbled, but March brought signs of life. This guid...
OpenAI has begun allowing users to link bank accounts to ChatGPT, turning the chatbot into a real-time financial assi...
Nokomis Capital quietly builds a new position in Apple Hospitality REIT, underscoring a rising appetite for hospitali...
A rare bipartisan bill moving through Congress would permanently establish a national AI research resource, reshaping...
Carl Icahn steps back from the activist spotlight as Michael Dell solidifies a long-term playbook for Dell Technologi...
Meta’s foray into cloud services, dubbed Meta Compute, sparks a selloff in AI infrastructure peers Nebius, CoreWeave,...
A Vanguard executive weighs in on the Trump Accounts proposal, praising potential early funding while cautioning that...
Robinhood Chain goes live on mainnet, delivering Layer 2 scalability for tokenized assets and a suite of around-the-c...
A notable new stake in Kyndryl signals growing confidence from a private equity–style shop. This deep dive explains w...